Discovery and in Vitro Optimization of 3-Sulfamoylbenzamides as ROMK Inhibitors.

Publication

Citation
Sammons MF, Kharade SV, Filipski KJ, Boehm M, Smith AC, Shavnya A, Fernando DP, Dowling MS, Carpino PA, Castle NA, Zellmer SG, Antonio BM, Gosset JR, Carlo A, Denton JS.: Discovery and in Vitro Optimization of 3-Sulfamoylbenzamides as ROMK Inhibitors. ACS Med Chem Lett, Volume 9 (2), 2018
Authors
Antonio BM, Boehm M, Carlo A, Carpino PA, Castle NA, Denton JS., Dowling MS, Fernando DP, Filipski KJ, Gosset JR, Kharade SV, Sammons MF, Shavnya A, Smith AC, Zellmer SG
Journal
ACS Med Chem Lett
Year
2018
PubMed
29456800
Machine-readable
REST APIRDF
Palacky University Olomouc

Palacky University Olomouc

Faculty of Science

Department of Physical Chemistry

tř. 17. listopadu 1192/12

771 46 Olomouc

Czech Republic

How to cite?

Juračka J., Šrejber M., Melíková M., Bazgier V., Berka K.: MolMeDB: Molecules on Membranes Database. Database, Volume 2019, 2019, baz078, https://doi.org/10.1093/database/baz078

Follow us

FacebookGithub

Financial Support

  • MolMeDB interoperability with UniProt and SwissLipids – MEYS Czech-Swiss project ELIXIR-IMPACT 8K0208 (2026–2028)
ELIXIRGAČRUP Olomouc
Discovery and in Vitro Optimization of 3-Sulfamoylbenzamides as ROMK Inhibitors. | MolMeDB